- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02055417
Increasing Motivation for Antiretroviral Therapy Initiation: A Pilot Intervention
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Many persons with HIV refuse recommended treatment or delay initiation of antiretroviral therapy (ART). Widespread belief in conspiracy theories regarding the origin and treatment of HIV may complicate the ART decision-making process. Research has found that conspiracy beliefs and mistrust in the mainstream medical system are common among African-Americans attending an HIV primary care clinic and that conspiracy beliefs are more likely to be held by patients who are not on ART. Moreover, research shows that conspiracy beliefs and other maladaptive cognitions predict subsequent readiness to begin ART. The investigators have developed an intervention called PATCH: Personal Approaches to Treatment Choices for HIV. PATCH is a brief intervention designed to support participants' decision-making processes and enhance intrinsic motivation to initiate ART, using motivational interviewing (MI) techniques. The intervention targets HIV-positive African-American adults in inner-city Baltimore, Maryland who are suboptimally engaged in care and who endorse conspiracy beliefs about HIV or low readiness to begin ART.
In this project the investigators will conduct a small randomized controlled pilot trial to test the potential efficacy of PATCH in producing positive attitudinal changes, including a reduction in conspiracy beliefs and perceived barriers to ART and an increase in stated readiness to begin ART. The investigators will compare PATCH to an attentional control. Participants will be recruited from outpatient HIV clinics settings but will be individuals who are not taking ART. Assessments will be conducted at baseline, post-treatment (estimated 4-8 weeks post-baseline), and at 3-month post-baseline follow-up. The specific aims are: (1) Develop and refine a manual for a brief MI intervention to support ART decision-making and reduce the likelihood of ART refusal: (2) Evaluate the feasibility and acceptability of implementing the PATCH intervention in a small sample of individuals who are African-American, recommended for ART but who are not current taking it, and who experience multiple barriers to ART adherence; and (3) Conduct a small randomized controlled pilot to test the potential efficacy of the PATCH intervention in producing positive attitudinal changes, including a reduction in conspiracy beliefs and perceived barriers to ART and stated readiness to begin ART.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- University of Maryland School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Known to the recruitment site to be HIV-positive
- African-American or multiracial with African-American heritage.
- Able to speak and understand English.
At least one of the following:
- Sub-optimally involved in HIV care (defined as no regular source of HIV primary care, clinically eligible for ART but not taking it, or received an offer of ART in the last year but not currently taking it.
- Non-adherent to ART (defined as being offered ART but not taking it or not appropriately adhering to it (as reflected by a score of 10 or less on screening questionnaire) at the time of enrollment.
- Conspiracy beliefs (defined as a score of 10 or more on screening questionnaire or states that would not be ready to take ART if recommended).
Exclusion Criteria:
- Known diagnosis of mental retardation or dementia.
- Active psychosis or suicidality evident in initial interview.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Personal Approaches to Treatment Choices for HIV
PATCH is a brief intervention designed to support participants' decision-making processes and enhance intrinsic motivation to initiate ART.
|
Other Names:
|
|
Active Comparator: Stress Reduction Skills Program
SRSP includes training in stress reduction skills such as relaxation, problem solving, and expressing negative feelings.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
positive attitudinal changes
Time Frame: baseline, week 6
|
Positive attitudinal changes includes a reduction in conspiracy beliefs and perceived barriers to ART.
Attitudes will be assessed via questionnaires completed at the baseline, post treatment, and follow-up assessments.
|
baseline, week 6
|
|
Stated readiness to begin ART
Time Frame: baseline, week 6
|
Stated readiness to begin ART will be assessed via questionnaires and interviews completed at the post treatment assessment.
|
baseline, week 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Beginning ART
Time Frame: baseline, week 16
|
Beginning ART will be assessed via questionnaires and interviews completed at the follow-up assessment, as well as by review of the medical record.
|
baseline, week 16
|
Collaborators and Investigators
Investigators
- Principal Investigator: Melanie E Bennett, Ph.D., University of Maryland, Baltimore
- Principal Investigator: Seth Himelhoch, MD, MPH, University of Maryland, Baltimore
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HP-00047473
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RecruitingHIV Prevention | PrEP Adherence | HIV Related StigmaThailand
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RecruitingFeasibility | HIV Prevention | PrEP Uptake | Acceptability | HIV Self-testing | Male Partners of HIV-negative Postpartum WomenSouth Africa
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of BotswanaRecruitingPregnancy | HIV | Post-partum | HIV Antiretroviral Therapy (ART) AdherenceBotswana
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
Instituto Mexicano del Seguro SocialRecruitingWeight Loss | HIV | HIV-1 Infection | Weight Change | HIV Associate Weight Loss | Integrase Inhibitors, HIV; HIV PROTEASE INHIBMexico
Clinical Trials on Personal Approaches to Treatment Choices for HIV
-
Massachusetts General HospitalUniversity of Colorado, DenverCompletedAortic Valve StenosisUnited States
-
Texas Christian UniversityActive, not recruitingMapping Approaches to Prepare for Implementation Transfer | Treatment Readiness and Induction ProgramUnited States
-
VA Office of Research and DevelopmentUniversity of Alabama at Birmingham; Providence VA Medical Center; Edith Nourse... and other collaboratorsActive, not recruitingEffectiveness and Implementation of Montessori Approaches in Person-Centered Care Within VA (MAP-VA)Dementia or a Related Disorder | Mental Health Diagnoses | Symptoms of Agitation or AggressionUnited States
-
University of California, Los AngelesMedical University of South Carolina; Charles University, Czech Republic; Human...CompletedHuman Immunodeficiency VirusSouth Africa
-
Emory UniversityCompletedHIVUnited States, South Africa
-
Changhai HospitalActive, not recruitingDiabetes Mellitus | Chronic PancreatitisChina
-
Medical University of South CarolinaNational Institute of Mental Health (NIMH)Completed
-
Boston UniversityBill and Melinda Gates Foundation; HE2RO, University of the WitwatersrandRecruiting
-
Multnomah County Health DepartmentOregon Department of Human ServicesCompletedHIV Infections | Sexually Transmitted Diseases | Domestic ViolenceUnited States